CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

basic care clearlax

InstaLax Polyethylene Glycol 3350· ingredient polyethylene glycol 3350· POLYETHYLENE GLYCOL 3350 17 g/1; POLYETHYLENE GLYCOL 3350 17 g/17g; POLYETHYLENE GLYCOL 3350 17 g/d; POLYETHYLENE GLYCOL 3350 17 g/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.02458
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 8 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other polyethylene glycol 3350 products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
GaviLyte - C TM$0.00373−$0.02090
GAVILYTE G TM$0.00465−$0.01990
GAVILYTE-N$0.00569−$0.01890
SUFLAVE$61.64+$61.62

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.